[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sinopharm Group Co Ltd (1099) - Financial and Strategic SWOT Analysis Review

May 2021 | 50 pages | ID: S950EAD2EA7EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sinopharm Group Co Ltd (1099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp, distributes pharmaceutical and healthcare products. The company provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies and other healthcare products. It also serves hospitals, primary health services institutions and retail drug stores. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents, laboratory supplies, and engages in the innovation of pharmaceutical, medical services and other health-related industries. Besides, the group manages a chain of medicine stores across China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.

Sinopharm Group Co Ltd Key Recent Developments

Apr 12,2021: Basler expands cooperation with Sinopharm for medical and life sciences market to greater China and South Korea
Apr 06,2021: Sinovac, Sinopharm show safety, efficacy: WHO
Mar 25,2021: China Eastern flies vaccines to Dominican Republic
Mar 22,2021: Sinopharm Annual Results Announcement For The Year Ended 31 December 2020
Mar 22,2021: Sinopharm Group Announces 2020 Annual Results Continues to Consolidate Industry Position The Profitability is Strong

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Sinopharm Group Co Ltd - Key Facts
Sinopharm Group Co Ltd - Key Employees
Sinopharm Group Co Ltd - Key Employee Biographies
Sinopharm Group Co Ltd - Major Products and Services
Sinopharm Group Co Ltd - History
Sinopharm Group Co Ltd - Company Statement
Sinopharm Group Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sinopharm Group Co Ltd - Business Description
Business Segment: Medical Devices
Overview
Performance
Business Segment: Other Business
Performance
Business Segment: Other Business Operations
Overview
Business Segment: Pharmaceutical Distribution
Key Stats
Business Segment: Pharmaceutical Distribution
Overview
Performance
Business Segment: Retail Pharmacy
Overview
Performance
Key Stats
Sinopharm Group Co Ltd - Corporate Strategy
Sinopharm Group Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sinopharm Group Co Ltd - Strengths
Sinopharm Group Co Ltd - Weaknesses
Sinopharm Group Co Ltd - Opportunities
Sinopharm Group Co Ltd - Threats
Sinopharm Group Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sinopharm Group Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 12, 2021: Basler expands cooperation with Sinopharm for medical and life sciences market to greater China and South Korea
Apr 06, 2021: Sinovac, Sinopharm show safety, efficacy: WHO
Mar 25, 2021: China Eastern flies vaccines to Dominican Republic
Mar 22, 2021: Sinopharm Annual Results Announcement For The Year Ended 31 December 2020
Mar 22, 2021: Sinopharm Group Announces 2020 Annual Results Continues to Consolidate Industry Position The Profitability is Strong
Mar 01, 2021: Sinopharm: Announcement resignation of supervisor and change of members of the senior management
Jan 14, 2021: Sinopharm: Announcement election of new chairman and change of composition of Board Committee
Jan 14, 2021: Sinopharm: Resignation Of Director and General Manager Of Sinopharm
Jan 12, 2021: Sinopharm Group : Resignation of the chairman of the company
Nov 11, 2020: China Global Import Expo: Signed deals worth 2.1% more than last year despite pandemic

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sinopharm Group Co Ltd, Key Facts
Sinopharm Group Co Ltd, Key Employees
Sinopharm Group Co Ltd, Key Employee Biographies
Sinopharm Group Co Ltd, Major Products and Services
Sinopharm Group Co Ltd, History
Sinopharm Group Co Ltd, Subsidiaries
Sinopharm Group Co Ltd, Joint Venture
Sinopharm Group Co Ltd, Key Competitors
Sinopharm Group Co Ltd, Ratios based on current share price
Sinopharm Group Co Ltd, Annual Ratios
Sinopharm Group Co Ltd, Annual Ratios (Cont...1)
Sinopharm Group Co Ltd, Annual Ratios (Cont...2)
Sinopharm Group Co Ltd, Interim Ratios
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sinopharm Group Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Sinopharm Group Co Ltd, Performance Chart (2016 - 2020)
Sinopharm Group Co Ltd, Ratio Charts
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications